Natixis’s Agilon Health AGL Stock Holding History
Bought
Maintained
Sold
Other funds holding AGL
CDR
NPCM
Natixis's AGL Position: Q4 2025 in Review
Natixis sold out of Agilon Health (AGL) in Q4 2025, closing a stake of 6,921 shares — an estimated $178K sold.
Natixis first reported a position in AGL in Q2 2022 and held it in 7 quarters. The position peaked at $5.24M in Q2 2022. 194 funds tracked by Wall St. Rank hold AGL as of Q4 2025.
- Natixis reported no remaining Agilon Health position as of Q4 2025 after selling out during the quarter.
- Natixis sold 6,921 Agilon Health shares in Q4 2025, an estimated $178K.
- Natixis first reported a position in Agilon Health in Q2 2022 and held it in 7 quarters.
- Natixis's Agilon Health position peaked at $5.24M in Q2 2022.
- 194 funds tracked by Wall St. Rank held Agilon Health as of Q4 2025.
Based on Natixis's 13F filing for Q4 2025, filed 13 Feb 2026.